Cera Sanitaryware Share Price Target 2026, 2027, 2028, 2029, 2030
- Market Cap
- ₹8,118 Cr
- Book Value
- ₹1,049.00
- Stock P/E
- 32.8
- Dividend Yield
- 1.19%
- ROE
- 18.2%
- ROCE
- 22.4%
- PEG Ratio
- 1.96
- EV/EBITDA
- 22.7
Fundamentals from Screener.in, as of 6 Aug 2026. Live price via Yahoo Finance.
Cera Sanitaryware share price today
Cera Sanitaryware Ltd (NSE: CERA) sat at ₹6,062 in Gale’s internal 6 August 2026 snapshot, with a market capitalisation of ₹8,118 crore. The same dated record showed a 52-week range of ₹4,524.30 to ₹6,661.50, so the share was roughly 9% below its high. The box above can move with the market; every ratio and model input below remains anchored to the dated snapshot so a live quote is never blended silently with older fundamentals.
The central question is not whether bathrooms are a structural growth category. Urbanisation, housing completions, replacement demand and the shift from unbranded fittings all support that case. The harder question is whether CERA can turn its new multi-brand architecture into faster growth without making trade discounts and advertising permanently heavier. FY26 revenue grew while profit and returns weakened. Q1 FY27 then delivered much faster sales growth but still lower year-on-year profit. That is credible recovery evidence, but not yet complete margin recovery.
What Cera Sanitaryware actually sells
CERA is a building-products brand rather than a single sanitaryware factory. It sells sanitaryware, faucets, tiles and wellness products across core CERA, premium CERA Luxe, luxury-focused Senator and value-oriented Polipluz. This breadth lets the company address different budgets while using common relationships with dealers, plumbers, architects and developers.
FY26 mix shows why faucetware now matters almost as much as the original ceramics franchise. Sanitaryware remained the largest category, but its 48% revenue share was only seven percentage points above faucetware. Tiles broaden the basket but carry different sourcing and margin economics; wellness remains small.
| FY26 product mix | Share of revenue | Reported category growth |
|---|---|---|
| Sanitaryware | 48% | 5.4% |
| Faucetware | 41% | 13.7% |
| Tiles | 10% | Not separately disclosed in the cited summary |
| Wellness | 1% | Not separately disclosed in the cited summary |
The economic attraction is distribution plus brand trust. A basin or faucet is bought infrequently, so a customer often relies on the dealer, plumber or architect. Availability, installation support and confidence in replacement parts can matter as much as an advertisement. The risk is that brand-building expenditure must be repeated, while low-cost regional and unorganised competitors can still compete aggressively on price.
Q1 FY27: sales accelerated before profit did
CERA released its June-quarter results on 7 August 2026, one day after Gale’s market snapshot. The two dates are deliberately separated here. Standalone revenue from operations rose 19.5% year on year to ₹485.98 crore, while total income increased 19.2% to ₹507.27 crore. Profit before tax declined 2.2% and net profit declined 2.6%. Basic EPS was ₹35.13 against ₹36.08.
| Standalone Q1 measure | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | ₹485.98 Cr | ₹406.81 Cr | +19.5% |
| Total income | ₹507.27 Cr | ₹425.41 Cr | +19.2% |
| Profit before tax | ₹59.81 Cr | ₹61.14 Cr | -2.2% |
| Profit after tax | ₹45.31 Cr | ₹46.53 Cr | -2.6% |
| Basic EPS | ₹35.13 | ₹36.08 | -2.6% |
The quarter says demand and distribution improved, but revenue quality still needs testing. Employee expense rose to ₹78.37 crore from ₹64.52 crore, and other expenses increased to ₹95.19 crore from ₹91.14 crore. Scale did not yet translate into proportionate profit. Investors should look for sequential normalisation in discounts, brand-launch costs and product mix rather than assuming that double-digit revenue growth automatically restores the old margin.
FY26 was an investment year with a lower margin
The FY26 investor presentation recorded revenue of ₹2,050 crore, up from ₹1,915 crore. EBITDA fell to ₹322 crore from ₹353 crore and profit after tax declined to ₹204 crore from ₹246 crore. EBITDA margin moved from 17.8% to 15.3%, while return on capital employed and return on equity also eased.
| Standalone full-year measure | FY25 | FY26 | Reading |
|---|---|---|---|
| Revenue | ₹1,915 Cr | ₹2,050 Cr | 7% growth despite soft category demand |
| EBITDA | ₹353 Cr | ₹322 Cr | Brand and channel investment weighed on profit |
| EBITDA margin | 17.8% | 15.3% | 250-bps compression |
| Profit after tax | ₹246 Cr | ₹204 Cr | 17% decline |
| ROCE | 21% | 18% | Still healthy, but moving in the wrong direction |
| ROE | 18% | 14% | Lower earnings on a larger equity base |
Management attributed the pressure to elevated trade support, investment behind Senator and Polipluz and higher brand expenditure. Those choices may build future revenue, but shareholders should demand measurable payback. The useful test is not how many dealers or stores are announced; it is whether revenue per outlet, gross profit and repeat orders rise after launch costs settle.
Four brands create reach and execution risk
The brand architecture is ambitious. Senator targets luxury bathroom solutions, CERA Luxe extends the premium offering, the mother brand serves the mass-premium customer, and Polipluz offers an organised alternative to unbranded value products. During FY26, CERA established dedicated sales teams, opened 40 Senator flagship stores and onboarded 102 Polipluz distributors and 1,120 dealers.
| Brand | Intended position | Evidence to monitor |
|---|---|---|
| Senator | Luxury and design-led complete bathrooms | Store productivity and premium gross margin |
| CERA Luxe | Premium extension of the core franchise | Cross-selling without confusing the mother brand |
| CERA | Mass-premium, trusted national brand | Market share and dealer throughput |
| Polipluz | Value segment versus unbranded supply | Distribution depth without excessive credit or discounting |
Segmentation can protect pricing because every customer is not pushed into one range. It can also duplicate sales effort, inventory and advertising. A successful portfolio produces clear price ladders and shared service economics. An unsuccessful one creates more stock-keeping units and working capital while customers struggle to understand the differences.
Manufacturing is deliberately hybrid
CERA combines in-house production with outsourced products. In FY26, 59% of sanitaryware revenue came from outsourced products and 41% from company-manufactured output. Faucetware was more integrated: 53% was manufactured internally and 47% outsourced. That model gives flexibility in design and demand cycles, but supplier quality and availability must be governed tightly.
| FY26 sourcing mix | Outsourced | Manufactured in-house |
|---|---|---|
| Sanitaryware revenue | 59% | 41% |
| Faucetware revenue | 47% | 53% |
The balance is not inherently good or bad. Outsourcing reduces fixed-capital intensity and broadens the catalogue; internal production improves process control and can capture more value. The correct mix depends on volumes, defect rates, lead times and landed cost. Investors should be cautious if growth comes mainly through low-margin traded products while owned assets remain underused.
Faucetware capacity can support the next leg
Management is increasing monthly faucetware capacity from four lakh to five lakh units through brownfield debottlenecking, with commissioning expected during FY27. The project requires only about ₹4–5 crore and is funded through internal accruals. Sanitaryware capacity utilisation remained below peak, leaving room for volume growth without immediate large-scale capital spending.
This is favourable capital allocation if demand fills the capacity and in-house economics beat outsourcing. It is less favourable if the added line merely shifts volume from suppliers without improving quality or contribution. Total FY27 capital expenditure was expected at ₹43–45 crore, including routine maintenance and office-space acquisition, so the faucet project itself is not the main balance-sheet risk.
Cash conversion is the strongest counterweight
Management’s FY26 performance review reported ₹254 crore of cash generated from operations and ₹192 crore of free cash flow to the firm, compared with ₹89 crore in FY25. CERA remained net-cash positive, while net worth rose from ₹1,350 crore to ₹1,472 crore. This gives the company room to fund brand investment and modest capacity additions without relying on financial leverage.
| FY26 balance-sheet evidence | Reported outcome | Interpretation |
|---|---|---|
| Operating cash generation | ₹254 Cr | Earnings were supported by real cash inflow |
| Free cash flow to firm | ₹192 Cr | Improved from ₹89 Cr in FY25 |
| Net worth | ₹1,472 Cr | Up from ₹1,350 Cr |
| Balance-sheet position | Net cash positive | Low refinancing risk |
| Promoter pledge in Gale snapshot | 0% | No dated pledge overhang |
Cash strength does not excuse weak incremental returns. If advertising and trade support are investments, their future gross profit should exceed their cost. The net-cash balance should be valued as resilience, not as permission to accept any acquisition, store rollout or permanently higher expense ratio.
Working capital improved, with one caution
Inventory days eased to 71 from 73 and payable days rose to 58 from 56. Receivable days increased to 41 from 38 as CERA supported channel partners and project customers. The reported working-capital cycle improved to 54 days from 55, but the receivable movement deserves attention while new brands scale.
| Working-capital measure | FY25 | FY26 | Direction |
|---|---|---|---|
| Inventory days | 73 | 71 | Improved |
| Receivable days | 38 | 41 | Weakened modestly |
| Payable days | 56 | 58 | Added supplier funding |
| Cycle, days of turnover | 55 | 54 | Broadly stable to better |
Channel expansion sometimes produces apparent sales before consumer offtake. Clean growth should therefore show steady collections and controlled inventory, not only distributor additions. A sharp rise in receivables alongside promotional spending would be an early warning that reported demand is being financed by CERA.
Returns remain good, not invulnerable
Gale’s 6 August snapshot recorded 22.4% ROCE, 18.2% ROE, a 15% operating margin and debt to equity of only 0.05. Five-year sales and profit CAGRs were 10% and 17%. Those are strong building-products economics, but the FY26 presentation shows that annual returns can fall when brand investment and demand softness coincide.
| Internal snapshot metric | 6 Aug 2026 | What it says |
|---|---|---|
| Sales CAGR, five years | 10% | Steady rather than hyper-growth |
| Profit CAGR, five years | 17% | Historical operating leverage |
| Operating margin | 15% | Below the earlier high-teens level |
| ROCE | 22.4% | Quality return on operating capital |
| ROE / five-year ROE | 18.2% / 17% | Consistent shareholder returns |
| Debt/equity | 0.05 | Conservative financing |
The next phase should be judged on incremental return on capital. If existing sanitaryware assets absorb more volume and faucetware debottlenecking earns quickly, the company can grow with limited capital. If new brands need years of discounting and inventory, accounting ROCE can remain lower even as sales rise.
The numbers
| Metric | Internal 6 Aug 2026 snapshot |
|---|---|
| Market capitalisation | ₹8,118 Cr |
| Snapshot price | ₹6,062.00 |
| P/E · price/book | 32.8× · 6.00× |
| PEG · EV/EBITDA | 1.96 · 22.7× |
| EPS (TTM) | ₹191.89 |
| Book value per share | ₹1,049.00 |
| Dividend yield | 1.19% |
| 52-week range | ₹4,524.30 – ₹6,661.50 |
Valuation demands both growth and margin repair
At 32.8 times snapshot earnings and 22.7 times EV/EBITDA, CERA was priced as a quality branded compounder, not a distressed building-material producer. Price to book of six times also assumes that returns on equity remain durable. The valuation can work if double-digit revenue growth combines with a recovery in contribution margin. It becomes difficult if the company must keep spending heavily merely to protect market share.
This model begins with the internal TTM EPS of ₹191.89. Each scenario compounds that same starting EPS and applies a finite exit P/E. The bear case assumes respectable but slow earnings and de-rating; the base case assumes volume growth plus partial margin repair; the bull case requires successful brand segmentation, operating leverage and sustained premium economics.
| Scenario | EPS growth | Exit P/E | Required business outcome |
|---|---|---|---|
| Bear | 6% | 24× | Demand grows slowly and promotional intensity persists |
| Base | 12% | 31× | New distribution converts and margin recovers gradually |
| Bull | 17% | 38× | Brand portfolio scales with strong cash conversion |
Cera Sanitaryware share price target 2026 to 2030
These are scenario sensitivities, not forecasts. The 2026 year-end row applies only 147/365 of one year’s growth from the 6 August snapshot. Every later row adds one full year, then applies the stated P/E and rounds the displayed result to the nearest ₹5. The method prevents a mid-year starting EPS from receiving an unjustified full year of compounding.
Scenario warning: housing demand, input costs, discounts, brand expenditure, sourcing mix and market multiples can all differ materially from these assumptions. The table is a decision aid, not a promised price path or personalised recommendation.
What would improve or damage the thesis
The case would improve if Q1’s sales momentum continued, gross profit grew faster than brand expenditure, receivable days stayed controlled and faucetware capacity filled without a large working-capital build. Rising revenue per Senator store and Polipluz distributor would show that the portfolio architecture is doing more than increasing outlet counts.
The case would weaken if revenue growth required recurring trade support, receivables rose faster than sales, outsourced product quality hurt the brand or the premium strategy failed to lift mix. A housing slowdown can delay purchases, while gas, metal and logistics costs can squeeze margins before prices are reset.
| Review item | Constructive evidence | Warning evidence |
|---|---|---|
| Revenue quality | Consumer-led growth with clean collections | Distributor loading and longer credit |
| EBITDA margin | Recovery as launch costs settle | Promotions become structurally higher |
| New brands | Better outlet productivity and repeat orders | Store count rises without throughput |
| Faucetware project | High utilisation and improved contribution | Capacity remains underused |
| Cash flow | Cash profit tracks accounting profit | Inventory and receivables absorb recovery |
Should you buy Cera Sanitaryware at the current price?
CERA combines a trusted brand, flexible sourcing, low financial risk and attractive long-run returns. The latest quarter also shows that demand can accelerate. What remains unproven is how quickly that growth restores profit margins after an investment-heavy FY26. A premium multiple leaves less tolerance for a second year in which sales rise but profit does not.
Investors should compare price with evidence, not with the 52-week high. Existing holders can track margin, collections and brand productivity; prospective buyers can insist on a sufficient margin of safety for execution risk. Gale’s signed-in panel carries the current research classification, and the paid view contains its accumulation band. Neither replaces portfolio sizing or advice from a registered professional.
FAQ
What is the Cera Sanitaryware share price target for 2030?
Gale’s signed-in table shows bear, base and bull outcomes for 2026 through 2030. The values come from the disclosed EPS-growth and P/E assumptions, not from a guaranteed single-point prediction.
Why did CERA’s Q1 FY27 profit fall despite higher revenue?
Revenue grew strongly, but employee and other operating expenses rose and profit margins compressed year on year. Investors should watch whether promotional and brand-launch costs normalise as volumes scale.
Is Cera Sanitaryware debt free?
The company reported a net-cash-positive FY26 balance sheet, while Gale’s dated snapshot showed debt to equity of 0.05. Lease and working-capital obligations still matter even when conventional borrowing is low.
What are CERA’s main growth drivers?
The important drivers are organised-market share gains, housing and renovation demand, faucetware expansion, premium Senator distribution and value-segment reach through Polipluz. Execution and cash conversion decide whether those drivers create shareholder value.
What is the main risk in CERA’s valuation?
The biggest risk is paying a premium multiple before margin recovery is established. If discounting and brand spend remain high, earnings can lag revenue and both the growth assumption and exit multiple may disappoint.
When will Cera Sanitaryware report its next results?
Use Gale’s results calendar and verify the final date through CERA’s exchange filing or investor-relations page. Indicative dates can change before the board formally announces them.
Related research
Sources and methodology
- CERA Q1 FY27 unaudited financial results, filed on 7 August 2026.
- CERA FY26 annual report, including product mix, sourcing, capacity, cash flow and working-capital disclosures.
- CERA May 2026 investor presentation, for FY26 operating and return measures.
- CERA investor financial-information hub.
- Screener.in financials for Cera Sanitaryware, captured in Gale’s approved internal snapshot on 6 August 2026.
Official Q1 figures released on 7 August are labelled separately from the market and valuation snapshot dated 6 August. Scenario arithmetic uses the internal TTM EPS and does not treat management guidance as a promise.
This article is research and education, not personalised investment advice. Gale is not a SEBI-registered investment adviser. Price targets are scenario arithmetic, not promises. Do your own research and consult a registered adviser before acting.